Corcept Therapeutics, Inc. (CORT)
116.23
+2.20
(+1.93%)
USD |
NASDAQ |
Oct 02, 16:00
116.23
0.00 (0.00%)
After-Hours: 20:00
Corcept Therapeutics Market Cap : 12.54B for Oct. 2, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 02, 2026 | 12.54B |
| October 01, 2026 | 12.31B |
| September 30, 2026 | 12.44B |
| September 29, 2026 | 12.38B |
| September 28, 2026 | 12.48B |
| September 25, 2026 | 12.53B |
| September 24, 2026 | 12.79B |
| September 23, 2026 | 12.19B |
| September 22, 2026 | 12.68B |
| September 21, 2026 | 12.28B |
| September 18, 2026 | 11.90B |
| September 17, 2026 | 12.40B |
| September 16, 2026 | 12.07B |
| September 15, 2026 | 11.96B |
| September 14, 2026 | 12.07B |
| September 11, 2026 | 12.17B |
| September 10, 2026 | 12.40B |
| September 09, 2026 | 12.49B |
| September 08, 2026 | 12.30B |
| September 04, 2026 | 12.05B |
| September 03, 2026 | 12.17B |
| September 02, 2026 | 11.92B |
| September 01, 2026 | 12.24B |
| August 31, 2026 | 12.23B |
| August 28, 2026 | 12.29B |
| Date | Value |
|---|---|
| August 27, 2026 | 12.62B |
| August 26, 2026 | 12.93B |
| August 25, 2026 | 13.34B |
| August 24, 2026 | 13.30B |
| August 21, 2026 | 13.19B |
| August 20, 2026 | 13.06B |
| August 19, 2026 | 12.84B |
| August 18, 2026 | 12.75B |
| August 17, 2026 | 12.65B |
| August 14, 2026 | 12.35B |
| August 13, 2026 | 11.93B |
| August 12, 2026 | 12.11B |
| August 11, 2026 | 12.07B |
| August 10, 2026 | 12.33B |
| August 07, 2026 | 11.95B |
| August 06, 2026 | 11.65B |
| August 05, 2026 | 11.95B |
| August 04, 2026 | 11.85B |
| August 03, 2026 | 12.17B |
| July 31, 2026 | 12.36B |
| July 30, 2026 | 12.77B |
| July 29, 2026 | 10.03B |
| July 28, 2026 | 10.17B |
| July 27, 2026 | 9.834B |
| July 24, 2026 | 10.23B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Eli Lilly & Co. | 1.076T |
| Pfizer Inc. | 158.43B |
| Aclaris Therapeutics, Inc. | 613.83M |
| Bristol Myers Squibb Co. | 124.93B |
| Liquidia Corp. | 2.552B |
Market Cap Related Metrics
| PE Ratio | 277.60 |
| PS Ratio | 16.16 |
| Price to Book Value | 17.77 |
| Price to Free Cash Flow | 125.59 |
| Price | 116.23 |
| Earnings Yield | 0.36% |
| Operating PE Ratio | 2096.47 |
| Normalized PE Ratio | 277.60 |